Document:

EX-10.1

Exhibit 10.1

EXECUTION VERSION

AGREEMENT

     This Agreement, dated as of November 11, 2008 (“Agreement”), is by and among A. Schulman,
Inc., a Delaware corporation (the “Company”), Ramius LLC, a Delaware limited liability company
(“Ramius”) and the other persons and entities that are signatories hereto (collectively, the
“Ramius Group,” and each, individually, a “member” of the Ramius Group) which are or may be deemed
to be the members of a “group” with respect to the common stock of the Company, par value $1.00 per
share (the “Common Stock”), pursuant to Rule 13d-5 promulgated by the Securities and Exchange
Commission (the “SEC”) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

     WHEREAS, the Ramius Group has indicated that it intends to nominate candidates for the
Company’s Board of Directors (“Board”), and solicit proxies for the election thereof (the “Proxy
Solicitation”) in connection with the Company’s 2008 Annual Meeting of Stockholders (the “2008
Annual Meeting”) and has taken certain actions in furtherance thereof; and

     WHEREAS, the Company and each of the members of the Ramius Group have determined that the
interests of the Company and its stockholders would be best served by, among other things, avoiding
the Proxy Solicitation and the costs associated therewith;

     WHEREAS, the Company and each of the members of the Ramius Group believe that entering into
this Agreement is in the best interests of the Company and its stockholders.

     NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and
agreements contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereto, intending to be legally bound
hereby, agree as follows:

     1. Representations and Warranties of the Company. The Company hereby represents and
warrants to the Ramius Group that (a) this Agreement has been duly authorized, executed and
delivered by the Company, and is a valid and binding obligation of the Company, enforceable against
the Company in accordance with its terms, except as enforcement thereof may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or similar
laws generally affecting the rights of creditors and subject to general equity principles; and (b)
neither the execution of this Agreement nor the consummation of any of the transactions
contemplated hereby nor the fulfillment of the terms hereof, in each case in accordance with the
terms hereof, will conflict with, result in a breach or violation or imposition of any lien, charge
or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to
the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan
agreement or other agreement, obligation, condition, covenant or instrument to which the Company or
any of its subsidiaries is a party or bound or to which its or their property is subject.

     2. Representations and Warranties of the Ramius Group. Ramius and each member of the
Ramius Group represents and warrants to the Company that (a) this Agreement has been duly
authorized, executed and delivered by Ramius and each such member, and is a valid and binding
obligation of such member, enforceable against such member in accordance with its terms, except as
enforcement thereof may be limited by applicable bankruptcy, insolvency,

 

 

reorganization, moratorium, fraudulent conveyance or similar laws generally affecting the
rights of creditors and subject to general equity principles; (b) as of the date of this Agreement,
the Ramius Group currently beneficially owns in the aggregate 960,381 shares of Common Stock; and
(c) any person who becomes a member of the Ramius Group after the date hereof with respect to the
Common Stock, pursuant to Rule 13d-5 under the Exchange Act, shall agree to comply with the
provisions of this Agreement during the term hereof.

     3. No Ramius Nominations. No member of the Ramius Group shall nominate, or provide
notice to the Secretary of the Company of an intention to nominate, persons for election as
directors at the 2008 Annual Meeting. The Ramius Group hereby withdraws any letter providing
notice to the Secretary of the intention of Ramius to nominate persons for election as directors at
the 2008 Annual Meeting.

     4. Board Matters.

     (a) Concurrently with the execution of this Agreement, Dr. Peggy G. Miller shall withdraw her
acceptance of her nomination to stand for election as a director of the Company at the 2008 Annual
Meeting, and the Company will not, subject to the terms and conditions hereof, nominate at the 2008
Annual Meeting another candidate for election to the vacancy created by expiration of Dr. Miller’s
term (the “Vacancy”).

     (b) Concurrently with the execution of this Agreement, the Board will form a special committee
(the “Special Committee”) consisting of Howard R. Curd (Chair), David G. Birney and Lee D. Meyer,
for the purpose of identifying, reviewing the qualifications of, and recommending for appointment
by the Board of an independent director to fill the Vacancy (the “Independent Director”). The
Independent Director shall be a person recommended by the Special Committee and approved by the
Board no later than January 31, 2009, to serve as a director until the expiration of his or her
term at the Company’s 2009 Annual Meeting (assuming that the stockholders approve a proposal to
de-classify the Board at the 2008 Annual Meeting). The Independent Director will have experience
in such areas as would reasonably be expected to enhance the Board, consistent with the Company’s
Corporate Governance Guidelines relating to director qualifications and Board composition. The
Independent Director shall qualify as “independent” under the listing standards of The Nasdaq Stock
Market, Inc (Marketplace Rule 4200 and any successor thereto) and Item 407(a) of Regulation S-K
promulgated by the SEC, and shall be an individual that the Special Committee reasonably believes
does not have a relationship with either the Company or the Ramius Group that would impair the
independence of such director in carrying out the responsibilities of a director of the Company.
In making its recommendations, the Special Committee will consider and interview at least two
candidates suggested by each of the Company and Ramius, provided that such recommendations are
received by the Special Committee no later than December 31, 2008.

     (c) The Company shall include David G. Birney and John B. Yasinsky on the Board’s slate of
nominees for election as directors of the Company at the 2008 Annual Meeting for a one-year term
ending at the Company’s 2009 Annual Meeting, and until their successors have been duly elected and
qualified (assuming that the stockholders approve a proposal to de-classify the Board at the 2008
Annual Meeting); and use its reasonable best efforts to cause the election of such directors at the
Company’s 2008 Annual Meeting including, without limitation,

2

 

recommending that the Company’s stockholders vote in favor of the election of the director
nominees at the 2008 Annual Meeting and voting the shares of Common Stock represented by all
proxies granted by stockholders in connection with the solicitation of proxies by the Board in
connection with the meeting in favor of such directors, except for such proxies that specifically
indicate a vote to withhold authority with respect to such directors. The Company shall schedule
the 2008 Annual Meeting to be held on December 18, 2008, or if any stockholder timely nominates any
candidates for election to the Board at the 2008 Annual Meeting, then the 2008 Annual Meeting shall
be held at the discretion of the Company, but in any event no later than January 31, 2009.

     (d) Until the appointment of the Independent Director, the Company will maintain the size of
the Board at twelve (12) directors to enable the appointment of the Independent Director to fill
the Vacancy and agrees not to increase the size of the Board above twelve (12) directors before the
conclusion of the 2009 Annual Meeting without the prior written consent of Ramius.

     (e) The Ramius Group agrees to vote in favor of the Board’s slate of nominees for election as
directors of the Company at the 2008 Annual Meeting, provided that such slate consists of the
director nominees set forth in Section 4(c) above (and, if appropriate, the Independent Director),
or other director nominees acceptable to the Ramius Group. No member of the Ramius Group shall
take any position, make any statements or take any action inconsistent with the foregoing.

     (f) If at any time during the initial term of the Independent Director there shall occur a
vacancy in the Board seat previously occupied by the Independent Director by reason of his or her
resignation, removal, death or incapacity, then the Company shall reconstitute the Special
Committee and take all necessary action to promptly fill such vacancy with a person recommended by
the Special Committee, using the same process, criteria and conditions set forth in Section 4(b)
above.

     (g) Concurrently with the execution of this Agreement, the Company shall provide evidence,
reasonably satisfactory to Ramius, that the Board has authorized and approved this Agreement and
the execution and performance hereof.

     5. Standstill Period.

     (a) Each member of the Ramius Group agrees that, from the date of this Agreement until after
the date of the 2008 Annual Meeting (such period, the “Standstill Period”), without the prior
written consent of the Board specifically expressed in a written resolution adopted by a majority
vote of the entire Board, neither it nor any of its Affiliates or Associates under its control or
direction will, and it will cause each of its Affiliates and Associates under its control not to,
directly or indirectly, in any manner: (i) engage in any solicitation of proxies or consents to
vote any voting securities of the Company or become a participant in any election contest with
respect to the Company, in each case, with respect to the Company’s 2008 Annual Meeting, and, in
each case, except in accordance with Section 4(c) above; (ii) seek to influence any person with
respect to the voting or disposition of any securities of the Company at the Company’s 2008 Annual
Meeting of Stockholders, except in accordance with Section 4(c) above; provided, however, that any
member of the Ramius Group and any Affiliate or Associate of any such

3

 

member may disclose, publicly or otherwise, how it intends to vote or act with respect to any
securities of the Company, any stockholder proposal or other matter to be voted on by the
stockholders of the Company (other than the election of directors) and the reasons therefor; (iii)
otherwise act, alone or in concert with others, to seek to influence the management, the Board or
policies of the Company or initiate or take any action to obtain representation on the Board,
except as permitted expressly by this Agreement; or (iv) enter into any agreements with any third
party with respect to any of the foregoing, except in each case, as contemplated by this Agreement,
it being understood and agreed that nothing contained herein shall be construed to limit the
ability of any member of the Ramius Group and any Affiliate or Associate of any such member to form
a “group” pursuant to Rule 13d-5 promulgated by the SEC under the Exchange Act with, or acquire
additional shares of Common Stock from, any party.

     (b) Nothing contained in this Agreement shall limit any member of the Ramius Group or the
Associates or Affiliates of such member from taking any of the actions otherwise prohibited in this
Agreement in connection with the 2009 Annual Meeting of Stockholders, including without limitation,
nominating directors or soliciting proxies for the election of directors or other purposes at the
2009 Annual Meeting.

     (c) As used in this Agreement, the terms “Affiliate” and “Associate” shall have the
respective meanings set forth in Rule 12b-2 promulgated by the SEC under the Exchange Act; the
terms “beneficial owner” and “beneficial ownership” shall have the same meanings as set forth in
Rule 13d-3 promulgated by the SEC under the Exchange Act; and the terms “person” or “persons” shall
mean any individual, corporation (including not-for-profit), general or limited partnership,
limited liability company, joint venture, estate, trust, association, organization or other entity
of any kind or nature.

     (e) In the event that the Company is in material breach of its obligations under this
Agreement, including, without limitation, a failure to comply in any material respect with the
provisions of Sections 4 or 6 of this Agreement, and such material breach is not cured within 30
days after written notice thereof is provided to the Company by the Ramius Group, then in addition
to any other remedies that the members of the Ramius Group may have, the provisions of Section 3,
4(e) and Section 5(a) shall also terminate.

     6. Expenses. Within five business days after receiving documentation thereof, the
Company shall reimburse Ramius for the actual documented out-of-pocket third-party expenses (up to
a maximum of $25,000) incurred by the members of the Ramius Group in connection with the
anticipated proxy solicitation, the drafting, negotiation and execution of this Agreement and all
related activities and matters.

     7. Public Announcement. Ramius and the Company shall announce this Agreement and the
material terms hereof by means of a mutually acceptable joint press release no earlier than the
close of business on November 11, 2008. Ramius and the Company shall also be entitled to make all
filings required by the rules of the Securities and Exchange Commission.

     8. Specific Performance. Each of the members of the Ramius Group, on the one hand,
and the Company, on the other hand, acknowledges and agrees that irreparable injury to the other
party hereto would occur in the event any of the provisions of this Agreement were not

4

 

performed in accordance with their specific terms or were otherwise breached and that such
injury would not be adequately compensable in damages. It is accordingly agreed that the members
of the Ramius Group or any of them, on the one hand, and the Company, on the other hand (the
“Moving Party”), shall each be entitled to specific enforcement of, and injunctive relief to
prevent any violation of, the terms hereof, and the other party hereto will not take action,
directly or indirectly, in opposition to the Moving Party seeking such relief on the grounds that
any other remedy or relief is available at law or in equity.

     9. Jurisdiction; Applicable Law. Each of the parties hereto (a) consents to submit
itself to the personal jurisdiction of the Court of Chancery or other federal or state courts of
the State of Delaware in the event any dispute arises out of this Agreement or the transactions
contemplated by this Agreement, (b) agrees that it shall not attempt to deny or defeat such
personal jurisdiction by motion or other request for leave from any such court, (c) agrees that it
shall not bring any action relating to this Agreement or the transactions contemplated by this
Agreement in any court other than the Court of Chancery or other federal or state courts of the
State of Delaware, and each of the parties irrevocably waives the right to trial by jury, (d)
agrees to waive any bonding requirement under any applicable law, in the case any other party seeks
to enforce the terms by way of equitable relief and (e) each of the parties irrevocably consents to
service of process by first class certified mail, return receipt requested, postage prepaid, to the
address of such parties’ principal place of business or as otherwise provided by applicable law.
THIS AGREEMENT SHALL BE GOVERNED IN ALL RESPECTS, INCLUDING VALIDITY, INTERPRETATION AND EFFECT, BY
THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO CONTRACTS EXECUTED AND TO BE PERFORMED WHOLLY
WITHIN SUCH STATE WITHOUT GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES OF SUCH STATE.

     10. Representative. Each member of the Ramius Group hereby irrevocably appoints
Ramius as such member’s attorney-in-fact and representative (the “Ramius Representative”), in such
member’s place and stead, to do any and all things and to execute any and all documents and give
and receive any and all notices or instructions in connection with this Agreement and the
transactions contemplated hereby. The Company shall be entitled to rely, as being binding on each
member of the Ramius Group, upon any action taken by the Ramius Representative or upon any
document, notice, instruction or other writing given or executed by the Ramius Representative.

     11. Severability. If at any time subsequent to the date hereof, any provision of
this Agreement shall be held by any court of competent jurisdiction to be illegal, void or
unenforceable, such provision shall be of no force and effect, but the illegality or
unenforceability of such provision shall have no effect upon the legality or enforceability of any
other provision of this Agreement.

     12. Counterparts. This Agreement may be executed in two or more counterparts which
together shall constitute a single agreement.

     13. Entire Agreement; Amendment; Release. This Agreement contains the entire
understanding of the parties hereto with respect to its subject matter and supersedes all prior
agreements between the parties hereto. The Company, on the one hand, and the Ramius Group,

5

 

on the other hand, do hereby and forever release and discharge the other party, and all of its
respective successors in interest, and all its agents, officers, directors, members, partners,
stockholders, associates, affiliates, employees, representatives, attorneys, heirs, assigns, and/or
their successors in interest, from any and all claims, causes of action, liabilities, damages or
demands of whatever character which such party now has, whether known or unknown, against the other
party concerning or in any way related to the 2008 Annual Meeting. There are no restrictions,
agreements, promises, representations, warranties, covenants or undertakings between the parties
other than those expressly set forth herein. This Agreement may be amended only by a written
instrument duly executed by the parties hereto, or in the case of the Ramius Group, the Ramius
Representative, or their respective successors or assigns.

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

6

 

     IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the duly authorized
signatories of the parties as of the date hereof.

	 	 	 	 	 	 	 
	 	 	A. SCHULMAN, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Joseph M. Gingo	 	 
	 

	 	 	 	 	 	 
	 

	 	Name:
	 	Joseph M. Gingo	 	 
	 

	 	Title:
	 	President and Chief Executive Officer	 	 

	 	 	 	 	 	 	 	 	 
	PARCHE, LLC	 	RCG STARBOARD ADVISORS, LLC	 	 
	 

	 	 	 	By:
	 	Ramius LLC,	 	 
	STARBOARD VALUE & OPPORTUNITY FUND, LLC	 	 	 	its sole member	 	 
	By:

	 	RCG Starboard Advisors, LLC,	 	 	 	 	 	 
	 	 	their managing member	 	RAMIUS ENTERPRISE MASTER FUND LTD	 	 
	 

	 	 	 	By:
	 	Ramius Advisors, LLC,	 	 
	RAMIUS VALUE AND OPPORTUNITY MASTER FUND
LTD	 	 	 	its investment advisor	 	 
	By:	 	RCG Starboard Advisors, LLC, 
its investment manager	 	
RAMIUS ADVISORS, LLC	 	 
	 

	 	 	By:
	 	Ramius LLC,	 	 
	 

	 	 	 	 	 	its sole member	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	RAMIUS LLC	 	 
	 

	 	 	 	By:
	 	C4S & Co., L.L.C.,

as managing member	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	C4S & CO., L.L.C.	 	 

	 	 	 	 	 	 	 	 	 
	 	 	By:	 	/s/ Jeffrey M. Solomon	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name:
	 	Jeffrey M. Solomon	 	 
	 

	 	 	 	Title:
	 	Authorized Signatory	 	 

	 	 	 
	/s/ Jeffrey M. Solomon
 

JEFFREY M. SOLOMON

	 	  
	Individually and as attorney-in-fact for
	 	 
	Peter A. Cohen, Morgan B. Stark and
	 	 
	Thomas W. Strauss
	 	 

10EX-10.2

Exhibit 10.2

ADVISORY AGREEMENT

BETWEEN

DR. PEGGY G. MILLER AND

A. SCHULMAN, INC.

This Advisory Agreement dated November 7, 2008, (the “Agreement”) sets forth the agreement by and
between Dr. Peggy G. Miller (“Dr. Miller”) and A. Schulman, Inc. (“Company”) in connection with Dr.
Miller’s continuing relationship with the Company upon the expiration of her term as a director at
the 2008 Annual Meeting of Stockholders (the “2008 Annual Meeting”).

1. DR. MILLER’S UNDERTAKINGS AND OBLIGATIONS

In exchange for the undertakings and obligations of the Company set forth in Section 2 (and subject
to the mutual understandings listed in Section 3), Dr. Miller agrees that:

	 	•	 	Beginning on January 1, 2009 and continuing through December 31, 2009, she will
provide advice to the Company and the Chair of the Nominating and Corporate Governance
Committee concerning matters of governance generally, and more specifically the design
and implementation of a plan to provide oversight by the Nominating and Corporate
Governance Committee of the Company’s management relating to operational, financial and
strategic risks affecting its business (“Governance Advice”).
	 
	 	•	 	Dr. Miller will be generally available to consult with executive management of the
Company with regard to such Governance Advice up to a maximum of 16 hours per month.
	 
	 	•	 	On November 7, 2008, Dr. Miller will decline her nomination to stand for election as
a Director of the Company.
	 
	 	•	 	Dr. Miller covenants and agrees that she will not reveal, divulge or make known to
any person, firm or company, any Confidential Information without the prior express
written consent of the Company. “Confidential Information” shall mean financial
information, strategies and techniques, trade secrets, contract terms with vendors and
suppliers, supplier lists and data, and such other confidential, proprietary, or
sensitive information concerning or relating to (a) the Company or any of its
affiliates, or (b) any third party that has disclosed or provided any of the same to
the Company or its affiliates on a confidential basis. Confidential Information shall
not include (1) any information which is now or becomes generally available to the
public other than as a result of a wrongful disclosure by Dr. Miller, (2) any
information disclosed by Dr. Miller which she reasonably and in good faith believes is
required for the performance of his duties under this Agreement, (3) any information
which is lawfully received by Dr. Miller from a third party having no obligations of
confidentiality to the Company or its affiliates, or (4) any information compelled to
be disclosed by applicable law; provided that Dr. Miller, to the extent not prohibited
from so doing by applicable law, will give the Company prior written notice of the
information to be so disclosed pursuant to clause (4) of this sentence as far in
advance of its disclosure as may be practical, will disclose no more information than
is

1

 

	 	 	 	required and will cooperate with any attempts by the Company to obtain a protection
order or similar treatment.

2. THE COMPANY’S UNDERTAKINGS AND OBLIGATIONS

In exchange for the undertakings and obligations of Dr. Miller set forth in Section 1, the Company
agrees that:

	 	•	 	It will compensate Dr. Miller for the services provided hereunder in the amount of
$85,000, payable in four equal installments on the first business day of each calendar
quarter in 2009.
	 
	 	•	 	Dr. Miller will be granted an award of 2,500 shares of restricted stock on or about
January 1, 2009.
	 
	 	•	 	Except as otherwise provided by this Agreement, nonqualified stock options,
restricted stock and restricted stock units previously granted to Dr. Miller will
remain subject to and will be treated in accordance with the terms and conditions of
the respective stock plans and award agreements pursuant to which they were granted.
	 
	 	•	 	Dr. Miller’s fully vested nonqualified stock options will not be adversely affected
by this Agreement or her retirement from the Board of Directors and will remain
exercisable at the existing exercise prices until the respective expiration dates set
forth in each of the stock option award agreements. Dr. Miller shall remain solely
responsible for any taxes due upon exercise of such stock options.
	 
	 	•	 	The waiver of all remaining vesting periods relating to the shares of restricted
stock or restricted stock units previously issued to Dr. Miller has been duly
authorized, so that all forfeiture provisions shall lapse upon Dr. Miller’s retirement
from the Board of Directors, provided Dr. Miller shall remain solely responsible for
any taxes due upon the lapse of such restrictions and vesting of such shares. The
parties hereby agree and acknowledge that the foregoing vesting provision shall be an
amendment to the restricted stock award agreements of Dr. Miller granted under the A.
Schulman, Inc. 2002 Equity Incentive Plan and the restricted stock award agreements and
restricted stock unit award agreement of Dr. Miller granted under the A. Schulman, Inc.
2006 Incentive Plan. Any restricted stock units that become vested pursuant to this
paragraph shall be settled no later than 60 days following Dr. Miller’s “separation
from service” within the meaning of Section 409A of the Internal Revenue Code of 1986,
as amended (the “Code”), with the Company and all persons with whom the Company is
considered a single employer under Sections 414(b) and (c) of the Code. The parties
hereby agree and acknowledge that the foregoing settlement provision shall be an
amendment to the restricted stock unit award agreement of Dr. Miller granted under the
A. Schulman, Inc. 2006 Incentive Plan.
	 
	 	•	 	Consultations with Dr. Miller will be scheduled in a manner reasonably convenient to
Dr. Miller and consistent with the nature of the consultation and the Company will
reimburse Dr. Miller for any reasonable expenses incurred during the course of those
consultations in accordance with the Company’s regular expense reimbursement policies.
Any requested services which go beyond the Governance Advice

2

 

	 	 	 	contemplated by this Agreement will be subject to entering into a mutually acceptable
separate agreement.
	 
	 	•	 	Both before and after the date of this Advisory Agreement and in addition to any
obligations imposed by law upon any successor to the Company, the Company will require
any successor (whether direct or indirect, by purchase, merger, consolidation or
otherwise) to all or substantially all of the business and/or assets of the Company to
agree in writing to assume the undertakings and obligations of this Agreement and to
perform in the same manner and to the same extent that the Company would be required to
perform it if no succession had taken place. Failure of the Company to obtain this
agreement from a Company successor before the effectiveness of any succession will be a
breach of this Advisory Agreement and will entitle Dr. Miller to receive immediately
any compensation remaining from the Company or its successor in the amount described in
Section 2, but Dr. Miller shall have no further obligation to provide the Governance
Advice. However, all other undertakings and obligations of the parties hereto shall
remain in full force and effect, including but not limited, to the gross-up obligation
and indemnification provisions. Except as provided in this section, this Advisory
Agreement is not assignable by either Party without the written consent of the other
Party.
	 
	 	•	 	The Company will continue to indemnify Dr. Miller pursuant to the terms of the
Indemnification Agreement, dated October 17, 2006, by and between the Company and
Dr. Miller, and to the full extent permitted by law, pursuant to the Company’s
Certificate of Incorporation and By-Laws, and during the term hereof will cause
Dr. Miller to be named under and covered by a directors’ and officers’ liability
insurance policy at least to the same extent as other persons then serving as directors
or executive officers of the Company.

3. DR. MILLER’S AND THE COMPANY’S MUTUAL UNDERSTANDINGS AND AGREEMENTS

Dr. Miller and the Company also agree and understand that:

	 	•	 	The Company and Dr. Miller will mutually agree upon any press release or any other
public announcement or statement with respect to the transactions contemplated by this
Agreement specifically or in any manner relating to the Company and Dr. Miller’s
longstanding service as a director. Neither the Company nor Dr. Miller shall issue any
such press release, other public announcement or other public statements prior to such
consultation and mutual agreement, except as, in the reasonable judgment of the
relevant party, may be required by applicable law, court process or by obligations
pursuant to any listing agreement with any national securities exchange.
	 
	 	•	 	It is intended that this Agreement comply with Section 409A of the Code and the
Treasury Regulations promulgated thereunder, and this Agreement will be interpreted,
administered and operated accordingly. Nothing herein shall be construed as an
entitlement to or guarantee of any particular tax treatment to Dr. Miller. Neither the
Company nor the Board of Directors of the Company shall have any liability with respect
to any failure to comply with the requirements of Section

3

 

	 	 	 	409A of the Code and the Treasury Regulations promulgated thereunder. Furthermore, the
Company may accelerate the time or schedule of a payment to Dr. Miller at any time this
Agreement fails to meet the requirements of Section 409A. Such payment may not exceed
the amount required to be included in income as a result of the failure to comply with
the requirements of Section 409A of the Code and the Treasury Regulations promulgated
thereunder.
	 
	 	•	 	Any disagreements about the effect of this Agreement will be resolved through
binding arbitration to be held in Akron, Ohio subject to the rules of the American
Arbitration Association and will be interpreted according to Ohio law.

4

 

	 	 	 	 	 	 	 	 	 
	A. SCHULMAN, INC.	 	 	 	DR. PEGGY G. MILLER	 	 
	 
	 	 	 	 	 	 	 	 
	By: 

Its:

	 	/s/ Joseph M. Gingo
 

President and Chief Executive Officer
	 	 
	 	/s/ Dr. Peggy G. Miller
 

	 	 
	 
	 	 	 	 	 	 	 	 
	Date: November 7, 2008	 	 	 	Date: November 7, 2008	 	 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}]]